The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study
Open accessThe DOI matches its Crossref record.
Abstract
STUDY OBJECTIVES: Insomnia is prevalent in patients with chronic obstructive pulmonary disease (COPD), and benzodiazepine receptor agonists (BZRAs) are the most commonly used drugs despite their adverse effects on respiratory function. The aim of this study was to investigate whether the use of BZRAs was associated with an increased risk of respiratory failure (RF) in COPD patients. DESIGN: Matched case-control study. SETTING: National Health Insurance Research Database (NHIRD) in Taiwan. PARTICIPANTS: The case group consisted of 2,434 COPD patients with RF, and the control group consisted of 2,434 COPD patients without RF, matched for age, sex, and date of enrollment. MEASUREMENTS AND RESULTS: Exposure to BZRAs during the 180-day period preceding the index date was analyzed and compared in the case and control groups. Conditional logistic regression was performed, and the use of BZRAs was associated with an increased risk of RF (adjusted odds ratio [aOR] 1.56, 95% confidence interval [CI] 1.14-2.13). In subgroup analysis, we found that the benzodiazepine (BZD) users had a higher risk of RF (aOR 1.58, 95% CI 1.14-2.20), whereas the risk in non-benzodiazepine (non-BZD) users was insignificant (aOR 0.85, 95% CI 0.51-1.44). A greater than 2-fold increase in risk was found in those who received two or more kinds of BZRAs and those using a combination of BZD and non-BZD medications. CONCLUSIONS: The use of benzodiazepine receptor agonists was a significant risk factor for respiratory failure in patients with chronic obstructive pulmonary disease (COPD). Compared to benzodiazepine, the prescription of non-benzodiazepine may be safer for the management of insomnia in COPD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chung, F., Memtsoudis, S. G., Ramachandran, S. K., Nagappa, M., Opperer, M., Cozowicz, C., Patrawala, S., Lam, D., Kumar, A., Joshi, G. P., et al. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001416 · Cited by 360
Brandt, J., & Leong, C. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0207-7 · Cited by 356
Associations among Neighborhood, Race, and Sleep Apnea Severity in Children. A Six-City Analysis
Wang, R., Dong, Y., Weng, J., Kontos, E. Z., Chervin, R. D., Rosen, C. L., Marcus, C. L., & Redline, S. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-662oc · Cited by 96
Chen, H., Cade, B. E., Gleason, K. J., Bjonnes, A. C., Stilp, A. M., Sofer, T., Conomos, M. P., Ancoli-Israel, S., Arens, R., Azarbarzin, A., et al. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0237oc · Cited by 82
Borker, P. V., Carmona, E., Essien, U. R., Saeed, G. J., Nouraie, S. M., Bakker, J. P., Stitt, C. J., Aloia, M. S., & Patel, S. R. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3685oc · Cited by 48
Risks of Zolpidem among Patients with Chronic Obstructive Pulmonary Disease
Castaneda, J. M., Hee Wai, T., Spece, L. J., Duan, K. I., Leonhard, A., Griffith, M. F., Plumley, R., Palen, B. N., Feemster, L. C., Au, D. H., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202307-654oc · Cited by 6
El-Solh, A. A., Lawson, Y., & Wilding, G. E. (2023) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s430609 · Cited by 5
“33,34 In short, while hypnotic agents produce significant improvements in total sleep time, subjective sleep latency, and frequency of arousals during sleep, they are responsible for myriad of respiratory and non-respiratory side effects, including worsening apneas, severe nocturnal desaturations,…”
Background
Metadata
- Authors
- Chen, S.-J., Yeh, C.-M., Chao, T.-F., Liu, C.-J., Wang, K.-L., Chen, T.-J., Chou, P., & Wang, F.-D.
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-07-01
- Volume
- 38
- Issue
- 7
- Pages
- 1045-1050
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W1490028980
- Cited by
- 93
- References
- 0
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.